Metraipolis › archive › dc_9aaec1a6dbe2

Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017 — Europe PMC PMID:38625902

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38625902
DOI
10.1371/journal.pone.0298628
License (as archived)
CC0-1.0
Archived
2026-10-06T18:47:54.155Z
SHA-256 of the archived text
aa7714961112bb3c996d9280b495cbcb2c55d31b9cb28cb0516b4522c7f61ff3
Stable URL of this page
https://metraipolis.com/documento/dc_9aaec1a6dbe2

How to cite

Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017 — Europe PMC PMID:38625902 — Europe PMC (en), https://europepmc.org/article/MED/38625902 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_9aaec1a6dbe2 (Metraipolis archive dc_9aaec1a6dbe2, sha256 aa7714961112bb3c996d9280b495cbcb2c55d31b9cb28cb0516b4522c7f61ff3)
BibTeX
@misc{dc9aaec1a6dbe2,
  title = {Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017 — Europe PMC PMID:38625902},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38625902},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_9aaec1a6dbe2; sha256 aa7714961112bb3c996d9280b495cbcb2c55d31b9cb28cb0516b4522c7f61ff3},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38625902. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Latent tuberculosis infection (LTBI) screening and treatment interventions that are tailored to optimize acceptance among the non-U.S.-born population are essential for U.S. tuberculosis elimination. We investigated the impact of medical interpreter use on LTBI treatment acceptance and completion among non-U.S.-born persons in a multisite study. Methods: The Tuberculosis Epidemiologic Studies Consortium was a prospective cohort study that enrolled participants at high risk for LTBI at ten U.S. sites with 18 affiliated clinics from 2012 to 2017. Non-U.S.-born participants with at least one positive tuberculosis infection test result were included in analyses. Characteristics associated with LTBI treatment offer, acceptance, and completion were evaluated using multivariable logistic regression with random intercepts to account for clustering by enrollment site. Our primary outcomes were whether use of an interpreter was associated with LTBI treatment acceptance and completion. We also evaluated whether interpreter usage was associated treatment offer and whether interpreter type was associated with treatment offer, acceptance, or completion. Results: Among 8,761 non-U.S.-born participants, those who used an interpreter during the initial interview had a significantly greater odds of accepting LTBI treatment than those who did not use an interpreter. There was no association between use of an interpreter and a clinician's decision to offer treatment or treatment completion once accepted. Characteristics associated with lower odds of treatment being offered included experiencing homelessness and identifying as Pacific Islander persons. Lower treatment acceptance was observed in Black and Latino persons and lower treatment completion by participants experiencing homelessness. Successful treatment completion was associated with use of shorter rifamycin-based regimens. Interpreter type was not associated with LTBI treatment offer, acceptance, or completion. Conclusions: We found greater LTBI treatment acceptance was associated with interpreter use among non-U.S.-born individuals.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-04-16).
Identificativi: PMID 38625902 · PMCID PMC11020400 · DOI 10.1371/journal.pone.0298628.
Descrittori MeSH principali: Patient Acceptance of Health Care; Latent Tuberculosis.
Pagina: https://europepmc.org/article/MED/38625902 — https://doi.org/10.1371/journal.pone.0298628. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T17:12:53.350Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.